Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 23 | 0 | 3 | 0 | €90.50 | €95.79 | 5.850% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €128.30 | €137.63 | 7.275% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.54 | €22.78 | 116.084% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €42.20 | €82.93 | 96.519% |
| Icon plc | 15 | 0 | 3 | 0 | €279.50 | €318.99 | 14.130% |
| United Therapeutics | 15 | 0 | 0 | 0 | €217.50 | €289.92 | 33.297% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.59 | €26.01 | 20.456% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €150.00 | €215.54 | 43.692% |
| Amedisys Inc. | 13 | 0 | 2 | 0 | €84.00 | €92.26 | 9.833% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €69.00 | €86.72 | 25.677% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €155.05 | €182.96 | 18.001% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| Alkermes plc | 12 | 2 | 2 | 0 | €22.80 | €34.08 | 49.477% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €336.10 | €359.93 | 7.091% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €210.50 | €247.61 | 17.628% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €359.00 | €421.61 | 17.439% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €17.20 | €31.74 | 84.529% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €109.00 | €116.50 | 6.877% |
| LivaNova plc | 7 | 0 | 2 | 0 | €51.00 | €64.66 | 26.782% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €79.50 | €97.90 | 23.147% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €99.60 | €110.00 | 10.442% |